Aptamer Group Wins Shareholder Backing for £4.55m Fundraise

Aptamer Group Plc ( (GB:APTA) ) has provided an update.

Aptamer Group plc, a York, UK-based developer of Optimer synthetic binders used across medicine, diagnostics, and research, serves the antibody alternatives market through fee-for-service work with major pharmaceutical companies and aims to generate future licensing income from partnered assets. Listed on AIM since 2021, the company positions its technology as a more stable, reliable, and cost-effective alternative to traditional antibodies.

Aptamer Group has secured shareholder approval at a General Meeting for all resolutions linked to its previously announced fundraise, allowing all elements of the financing package to proceed. The company has now raised about £4.55 million via placings, subscriptions, and a retail offer, substantially enlarging its issued share capital and setting up the admission of the new shares to trading on AIM, which clarifies the capital base and voting rights for investors.

Spark’s Take on APTA Stock

According to Spark, TipRanks’ AI Analyst, APTA is a Underperform.

The score is primarily held down by very weak financial performance (sharp revenue collapse, continued losses, and negative cash flows). Technical indicators also remain bearish with the stock below major moving averages and negative MACD; oversold momentum readings provide only limited support. Valuation is constrained by a negative P/E and no dividend data.

To see Spark’s full report on APTA stock, click here.

More about Aptamer Group Plc

Aptamer Group plc is a life sciences company that develops next-generation synthetic binders, branded as Optimer, which function like antibodies by targeting specific molecules in the body. Its binders are used in therapeutics, diagnostics, and research tools, and the company operates a fee-for-service model in the global antibody alternatives market while building partnered assets for future licensing revenue.

Average Trading Volume: 5,372,801

Technical Sentiment Signal: Sell

Current Market Cap: £17.56M

See more data about APTA stock on TipRanks’ Stock Analysis page.